The Booming Menopause Market: Are the Products Worth It?
What: Courtney Rubin does a deep dive from Women’s Health on which menopause products work, and which don’t. The main advice? If it sounds too good to be true, it probably is.
Key Line: “Most of these menopause products are not actually harmful, but they’re potentially a waste of time and money… As for pricey menopause retreats? Dr. Faubion calls them ‘ridiculous.’”
Mouse study reveals female hormones help trigger opioid production in spinal cord immune cells.
Breast pump startup Willow takes over UK-based Elvie’s assets, signaling tough market conditions for women’s health companies.
Cancer incidence among women continues to rise despite overall progress.
The 19th highlights how removing “DEI” efforts puts research on women’s health at risk.
New Yorker review highlights how fetal rights are becoming the next legal front.
The Wall Street Journal examines why women in their 30s and 40s are opting for facelifts earlier than before.
Once academic, now viral—this disinfectant may be the most powerful skin-safe cleanser yet.
The U.S. Supreme Court appears inclined to allow Medicaid patients to continue receiving non-abortion care from Planned Parenthood.
Title X funds withheld due to diversity initiative crackdown, Politico reports.
Young women now outpace young men in binge drinking, a reversal from previous years.
JAMA study shows a 28% increase in maternal deaths from 2018 to 2022.
Meghan Markle discusses rare and life-threatening postpartum condition on new podcast.
NWLC report warns that birth control access is increasingly under threat post-Roe.
Luxury spa resort launches new “Inner Glow” retreat focused on hormone health and long-term wellness.
Trump administration floats baby bonuses, fertility funding, and fertility-focused Fulbrights.
A Stanford economist study found that women who sought menopause treatment made 10% less income four years later.
A class action lawsuit reveals dangerous conditions at one CPC, prompting ultrasound regulations.
Study finds no mass OBGYN flight from states with abortion bans—yet.
Trump promotes IVF access while cutting the team responsible for tracking it.
Interleukin-6 shows early promise in detecting life-threatening sepsis.